Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

George G. Glenner, Caine W. Wong · Biochemical and Biophysical Research Communications · 1984 · 5.3K citations

Initial Report, Alzheimer's Disease, Dementia +11

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Clifford R. Jack, David S. Knopman, William J. Jagust et al. · The Lancet Neurology · 2009 · 4.6K citations · Full text

Alzheimer's Disease, Dementia, Biomarkers +10

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

Victor L. Villemagne, Samantha C. Burnham, Pierrick Bourgeat et al. · The Lancet Neurology · 2013 · 2.2K citations

Neurodegenerative Diseases, Alzheimer's Disease, Aging +11

Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier

Masayoshi Shibata, Shinya Yamada, S. Ram Kumar et al. · Journal of Clinical Investigation · 2000 · 1.4K citations · Full text

Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

Ronald B. DeMattos, Kelly R. Bales, David J. Cummins et al. · Proceedings of the National Academy of Sciences · 2001 · 1.3K citations · Full text

Immunology, Neurochemical Biomarkers, Neuroinflammation +19